Cardiac biosensors stand at the forefront of transformative healthcare technologies, revolutionizing the landscape of cardiovascular diagnostics and monitoring. These state-of-the-art biosensors employ sophisticated sensing mechanisms to identify specific biomarkers or physiological signals associated with cardiac health. The real-time and precise data provided by cardiac biosensors enable healthcare practitioners to make informed decisions promptly, ushering in a new era of personalized and responsive patient care. These biosensors are instrumental in the early identification, continuous monitoring, and effective management of cardiovascular conditions, significantly enhancing patient outcomes. As the field of biosensing technology evolves through ongoing research and development, the incorporation of cardiac biosensors promises to redefine the standards of cardiovascular healthcare, bringing forth a future where proactive and personalized cardiac monitoring becomes integral to the standard of care.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt